Lexicon Pharmaceuticals Inc (LXRX)
1.63
+0.01
(+0.62%)
USD |
NASDAQ |
Apr 18, 16:00
1.63
0.00 (0.00%)
After-Hours: 20:00
Lexicon Pharmaceuticals Cash and Short Term Investments (Quarterly): 170.03M for Dec. 31, 2023
Cash and Short Term Investments (Quarterly) Chart
Historical Cash and Short Term Investments (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 170.03M |
| September 30, 2023 | 218.43M |
| June 30, 2023 | 256.74M |
| March 31, 2023 | 105.94M |
| December 31, 2022 | 138.36M |
| September 30, 2022 | 136.20M |
| June 30, 2022 | 61.97M |
| March 31, 2022 | 86.50M |
| December 31, 2021 | 86.74M |
| September 30, 2021 | 120.92M |
| June 30, 2021 | 118.50M |
| March 31, 2021 | 141.36M |
| December 31, 2020 | 152.28M |
| September 30, 2020 | 111.45M |
| June 30, 2020 | 201.87M |
| March 31, 2020 | 249.14M |
| December 31, 2019 | 271.66M |
| September 30, 2019 | 296.30M |
| June 30, 2019 | 105.98M |
| March 31, 2019 | 133.14M |
| December 31, 2018 | 160.05M |
| September 30, 2018 | 187.30M |
| June 30, 2018 | 209.69M |
| March 31, 2018 | 262.27M |
| December 31, 2017 | 310.79M |
| Date | Value |
|---|---|
| September 30, 2017 | 196.82M |
| June 30, 2017 | 231.19M |
| March 31, 2017 | 259.74M |
| December 31, 2016 | 346.50M |
| September 30, 2016 | 395.56M |
| June 30, 2016 | 429.36M |
| March 31, 2016 | 477.15M |
| December 31, 2015 | 521.35M |
| September 30, 2015 | 256.42M |
| June 30, 2015 | 282.48M |
| March 31, 2015 | 315.10M |
| December 31, 2014 | 339.34M |
| September 30, 2014 | 57.87M |
| June 30, 2014 | 79.04M |
| March 31, 2014 | 98.37M |
| December 31, 2013 | 129.13M |
| September 30, 2013 | 151.21M |
| June 30, 2013 | 175.38M |
| March 31, 2013 | 197.16M |
| December 31, 2012 | 223.21M |
| September 30, 2012 | 206.85M |
| June 30, 2012 | 231.51M |
| March 31, 2012 | 253.66M |
| December 31, 2011 | 281.69M |
| September 30, 2011 | 144.16M |
Cash and Short Term Investments Definition
Cash and Short Term investments is the sum of two balance sheet line items: cash and equivalents and short term investments in marketable securities.
Cash and Short Term Investments (Quarterly) Range, Past 5 Years
61.97M
Minimum
Jun 2022
296.30M
Maximum
Sep 2019
159.49M
Average
138.36M
Median
Dec 2022
Cash and Short Term Investments (Quarterly) Benchmarks
| Novavax Inc | 568.50M |
| AIM ImmunoTech Inc | 13.07M |
| Perspective Therapeutics Inc | 9.238M |
| Protalix BioTherapeutics Inc | 44.56M |
| Armata Pharmaceuticals Inc | 13.52M |